123 related articles for article (PubMed ID: 12629724)
1. [Essential hypertension].
Murakami H; Shimamoto K
Nihon Rinsho; 2003 Jan; 61 Suppl 1():235-40. PubMed ID: 12629724
[No Abstract] [Full Text] [Related]
2. [Management of hyperuricemia in diabetes].
Hirai A; Saito Y
Nihon Rinsho; 1997 Nov; 55 Suppl():781-5. PubMed ID: 9434564
[No Abstract] [Full Text] [Related]
3. Effect of allopurinol on blood pressure and aortic compliance in hypertensive patients.
Kostka-Jeziorny K; Uruski P; Tykarski A
Blood Press; 2011 Apr; 20(2):104-10. PubMed ID: 21405957
[TBL] [Abstract][Full Text] [Related]
4. [Hyperuricemia in hypertension].
Tatsuno I
Nihon Rinsho; 2004 Mar; 62 Suppl 3():493-7. PubMed ID: 15171422
[No Abstract] [Full Text] [Related]
5. [Isolated or combined drug therapy of hyperuricemia?].
Mertz DP
Dtsch Med Wochenschr; 1977 Jul; 102(30):1096-7. PubMed ID: 891391
[No Abstract] [Full Text] [Related]
6. Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled crossover preliminary study.
Ogino K; Kato M; Furuse Y; Kinugasa Y; Ishida K; Osaki S; Kinugawa T; Igawa O; Hisatome I; Shigemasa C; Anker SD; Doehner W
Circ Heart Fail; 2010 Jan; 3(1):73-81. PubMed ID: 19933411
[TBL] [Abstract][Full Text] [Related]
7. [Hyperuricemia and gout--treatment].
Gröbner W; Walter-Sack I
Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
[No Abstract] [Full Text] [Related]
8. [Treatment of hyperuricemia and gout].
Gröbner W; Walter-Sack I
Med Monatsschr Pharm; 2005 May; 28(5):159-64; quiz 165-6. PubMed ID: 15912988
[No Abstract] [Full Text] [Related]
9. [Hyperuricemia and atherosclerosis].
Tatsuno I; Saito Y
Nihon Rinsho; 2003 Jan; 61 Suppl 1():259-65. PubMed ID: 12629728
[No Abstract] [Full Text] [Related]
10. Letter by George regarding article, "Uric acid-lowering treatment with benzbromarone in patients with heart failure: a double-blind placebo-controlled cross-over preliminary study".
George J
Circ Heart Fail; 2010 May; 3(3):e10; author reply e14. PubMed ID: 20484184
[No Abstract] [Full Text] [Related]
11. Stopping progression in familial juvenile hyperuricemic nephropathy with benzbromarone?
Lhotta K
Kidney Int; 2003 Nov; 64(5):1920-1. PubMed ID: 14531831
[No Abstract] [Full Text] [Related]
12. [Uricosuric agent].
Ohno I
Nihon Rinsho; 2008 Apr; 66(4):743-7. PubMed ID: 18409525
[TBL] [Abstract][Full Text] [Related]
13. [The uric acid-lowering action of benzbromarone effervescent granules and allopurinol. Comparative studies (author's transl)].
Mertz DP
MMW Munch Med Wochenschr; 1978 Oct; 120(42):1387-90. PubMed ID: 101792
[TBL] [Abstract][Full Text] [Related]
14. [Secondary hyperuricemia in Down's syndrome].
Okabe H; Mizuguchi M
Nihon Rinsho; 2003 Jan; 61 Suppl 1():318-22. PubMed ID: 12629739
[No Abstract] [Full Text] [Related]
15. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
Fujimori S
Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
[TBL] [Abstract][Full Text] [Related]
16. [Chronic gout. Case report of a severe course of disease].
Boxberger F; Harsch IA; Brueckl WM; Hautmann M; Baum U; Hahn EG; Wein A
Med Klin (Munich); 2003 Nov; 98(11):646-7. PubMed ID: 14631540
[No Abstract] [Full Text] [Related]
17. [Gout: physiopathology, diagnosis, course, treatment].
Chazerain P; Ziza JM
Rev Prat; 1998 Sep; 48(13):1453-6. PubMed ID: 10050628
[No Abstract] [Full Text] [Related]
18. The treatment of hyperuricemia in gout.
Rastegar A; Thier SO
Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829
[No Abstract] [Full Text] [Related]
19. Clinical efficacy and safety of benzbromarone in elderly hypertensive patients with hyperuricemia.
Gao H
Pak J Pharm Sci; 2019 Jul; 32(4(Supplementary)):1869-1871. PubMed ID: 31680085
[TBL] [Abstract][Full Text] [Related]
20. [Drug therapy of hyperuricemia].
Gröbner W
Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551
[No Abstract] [Full Text] [Related]
[Next] [New Search]